コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 similar to the MTS of the p13(II) protein of human T-cell leukemia virus type 1.
2 ses, hepatitis B virus, simian virus 40, and human T-cell leukemia virus type 1.
3 ed the import pathway for the Rex protein of human T-cell leukemia virus type 1.
4 ible mechanism of cellular transformation by human T-cell leukemia virus type 1.
5 ses, human immunodeficiency virus type 1 and human T-cell leukemia virus type 1.
9 hich include bovine leukemia virus (BLV) and human T-cell leukemia virus types 1 and 2 (HTLV-1 and -2
10 an essential regulator of RNA expression in human T-cell leukemia virus types 1 and 2 (HTLV-1 and HT
11 eukemia virus (BLV), a retrovirus related to human T-cell leukemia virus types 1 and 2, can induce pe
12 xicity due to HFV infection was seen in both human T-cell leukemia virus type 1- and human immunodefi
16 PDGF-B) proto-oncogene by the Tax protein of human T-cell leukemia virus type 1 has been implicated a
17 ification of additional human tumor viruses--human T-cell leukemia virus type 1, hepatitis C virus, a
18 erging viruses in the transplant population: human T-cell leukemia virus type 1; hepatitis E virus; b
27 Here we report the structure of a complex of human T cell leukemia virus type 1 (HTLV-1) PR with a su
28 uded separation of monocytic cells (U937) or human T cell leukemia virus type 1 (HTLV-1) tax-transfor
31 Tax, an oncogenic viral protein encoded by human T cell leukemia virus type 1 (HTLV-1), induces cel
32 L-induced apoptosis, we used TRAIL-resistant human T cell leukemia virus type 1 (HTLV-1)-associated a
33 l monocytes) to the total viral burden in 22 human T cell leukemia virus type 1 (HTLV-1)-infected ind
36 ct is required for efficient transmission of human T cell leukemia virus- type 1 (HTLV-I) between cel
38 teractions between the Tax transactivator of human T-cell leukemia virus type 1 (HTLV-1) and a cell c
39 ng that of important human pathogens such as human T-cell leukemia virus type 1 (HTLV-1) and HIV-1.
45 hich include bovine leukemia virus (BLV) and human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2,
46 uorescence techniques in real time with both human T-cell leukemia virus type 1 (HTLV-1) and human im
49 Sugata et al report that vaccination against human T-cell leukemia virus type 1 (HTLV-1) basic leucin
53 omosomally integrated form of the retrovirus human T-cell leukemia virus type 1 (HTLV-1) contains ide
57 Little is known about the requirements for human T-cell leukemia virus type 1 (HTLV-1) entry, inclu
58 oworkers proposed a model for this region of human T-cell leukemia virus type 1 (HTLV-1) Env in which
62 ), reticuloendotheliosis virus A (REV-A) and human T-cell leukemia virus type 1 (HTLV-1) exhibit PCE
63 present data showing that neither HIV-1 nor human T-cell leukemia virus type 1 (HTLV-1) expresses si
65 The PPPY motif in the matrix (MA) domain of human T-cell leukemia virus type 1 (HTLV-1) Gag associat
72 by conformational peptides derived from the human T-cell leukemia virus type 1 (HTLV-1) gp21 envelop
79 -alpha2a) has beneficial clinical effects on human T-cell leukemia virus type 1 (HTLV-1) infection, b
80 wn about the ability of NK cells to restrain human T-cell leukemia virus type 1 (HTLV-1) infection.
99 ll established that cell-free infection with human T-cell leukemia virus type 1 (HTLV-1) is less effi
118 f Blood, Fujikawa et al demonstrate that the human T-cell leukemia virus type 1 (HTLV-1) oncoprotein
121 been suggested to be largely dispensable for human T-cell leukemia virus type 1 (HTLV-1) particle bio
122 was recently shown to bind and activate the human T-cell leukemia virus type 1 (HTLV-1) promoter at
124 for expression and purification of wild-type human T-cell leukemia virus type 1 (HTLV-1) proteinase t
125 cell leukemia (ATL) cells contain integrated human T-cell leukemia virus type 1 (HTLV-1) proviruses.
131 mmunodeficiency virus type 1 (HIV-1) Rev and human T-cell leukemia virus type 1 (HTLV-1) Rex proteins
138 e high-risk human papillomavirus (HPV) E6 or human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprot
140 ion that is activated in the presence of the human T-cell leukemia virus type 1 (HTLV-1) Tax protein.
142 vators of the canonical pathway, and mediate human T-cell leukemia virus type 1 (HTLV-1) Tax-induced
143 rming protein from the pathogenic retrovirus human T-cell leukemia virus type 1 (HTLV-1) that activat
144 establishment of humanized mice infected by human T-cell leukemia virus type 1 (HTLV-1) that recapit
145 he R region of the long terminal repeat from human T-cell leukemia virus type 1 (HTLV-1) to the cytom
154 have indicated that the genetic diversity of human T-cell leukemia virus type 1 (HTLV-1), a virus ass
156 -1), Moloney murine leukemia virus (M-MuLV), human T-cell leukemia virus type 1 (HTLV-1), and human T
157 leukemia virus (BLV) and its close relative, human T-cell leukemia virus type 1 (HTLV-1), are still b
158 ous study, we found that HBZ, encoded by the Human T-cell Leukemia Virus type 1 (HTLV-1), binds to mu
159 mbers of the deltaretroviruses, for example, human T-cell leukemia virus type 1 (HTLV-1), have been e
160 e been recognized in retroviruses, including human T-cell leukemia virus type 1 (HTLV-1), HIV-1, and
161 ukemia, which can result from infection with human T-cell leukemia virus type 1 (HTLV-1), is associat
164 patitis C virus (HCV), HBV, cytomegalovirus, human T-cell leukemia virus type 1 (HTLV-1), or HTLV-2.
166 To develop a high-titer surrogate virus for human T-cell leukemia virus type 1 (HTLV-1), we generate
167 icted infection by HIV-1, HIV-1Deltavif, and human T-cell leukemia virus type 1 (HTLV-1), while signi
169 -free infection assay, utilizing recombinant human T-cell leukemia virus type 1 (HTLV-1)-based vector
172 esion molecule 1 (VCAM-1) are susceptible to human T-cell leukemia virus type 1 (HTLV-1)-induced sync
180 l 134 amino acid fragment (CA(134)) from the human T-cell leukemia virus type 1 (HTLV-I) using high r
183 candidate tumor suppressor, is repressed in human T-cell leukemia virus type-1 (HTLV-1)-transformed
187 ogenous level of BIC by up to 70% in EBV- or human T-cell leukemia virus type 1 (HTLV1)-transformed c
189 oth chromatin and cell extracts derived from human T-cell leukemia virus type 1-infected human T lymp
190 rase induces a severe telomere shortening in human T-cell leukemia virus type-1-infected cells which
196 virus (BLV; a retrovirus closely related to human T-cell leukemia virus type 1) is unknown; however,
198 with Tax, a transcriptional activator of the human T-cell leukemia virus type 1 long terminal repeat,
199 Tax, the virally encoded activator of the human T-cell leukemia virus type 1 long terminal repeats
203 rase to nucleosomal templates containing the human T-cell leukemia virus type-1 promoter sequences.
204 is disease it is important to comprehend how human T-cell leukemia virus type 1 promotes cellular gro
206 cts specifically with the NESs of HIV-1 Rev, human T-cell leukemia virus type 1 Rex, and equine infec
207 otifs at their C termini and, significantly, human T cell leukemia virus type 1 Tax and human papillo
211 from several investigators suggest that the human T-cell leukemia virus type 1 Tax oncoprotein repre
213 o-oncogene promoter is transactivated by the human T-cell leukemia virus type 1 Tax protein in human
217 in a mechanism similar to the interaction of human T-cell leukemia virus type 1 Tax with the cellular
218 proteins, including human papillomavirus E6, human T-cell leukemia virus type 1 Tax, and human adenov
219 cers, including tumor necrosis factor alpha, human T-cell leukemia virus type 1 Tax, Cot, and MEKK1.
220 us, human immunodeficiency virus type 1, and human T-cell leukemia virus type 1 that lack infectivity
222 stingly, PIF was constitutively activated in human T-cell leukemia virus type 1-transformed MT-2 cell
223 udding requires a specific role for lysines, human T-cell leukemia virus type 1, which does not bud w
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。